Optimizing pegylated asparaginase use: An institutional guideline for dosing, monitoring, and managementNajeebah A. Bade, Ashkan Emadi, Crystal Lu et al.|Journal of Oncology Pharmacy Practice|2019Cited by 42
Treatment of High Risk (HR) Smoldering Multiple Myeloma (SMM) with Carfilzomib, Lenalidomide, and Dexamethasone (KRd) Followed By Lenalidomide Maintenance (-R): A Phase 2 Clinical and Correlative StudyDickran Kazandjian, Ola Landgren, Elisabet E. Manasanch et al.|Blood|2020Cited by 10